EMA Suggests More Recalls as Form 483s Come to Light for Ben Venue-Made Products

Manufacturing woes for Boehringer Ingelheim’s (BI) Ben Venue Laboratories continue as the FDA made public two Form 483s with dozens of observations made during two inspections of an Ohio manufacturing facility and the European Medicines Agency (EMA) recommended recalls of multiple products manufactured by Ben Venue.
Drug Industry Daily